Issue 24 | Week of 14 September 2026 Cardiology Intelligence Briefing: diagnosis outpaces treatment This was a week in which cardiology got sharper at telling patients apart, while two plausible treatments failed to deliver.34 A large European cohort showed that combining cardiac imaging with genetic testing separates high and low
Issue 23 | Week of 7th September 2026 ESC Congress 2026 concluded in Munich on 31 August. This issue covers papers first published on 30 and 31 August, plus CARDIO-TTRansform, first published on 28 August and held over from last issue by editorial choice. Cardiology Intelligence Briefing: what a result
Issue 22 | Week of 1 September 2026 ESC Congress 2026 is taking place in Munich this week, running from 28 to 31 August, one of the largest Hot Line weeks in the meeting's recent history. This issue covers papers first published on 28 and 29 August; papers first
Issue 21 | Week of 24 August 2026 No major cardiology congress fell this week. The European Society of Cardiology (ESC) Congress 2026 begins next week in Munich, running 28 to 31 August. Cardiology Intelligence Briefing: how far the evidence travels Once a therapy, test, or clinical pathway has been shown
Issue 20 | Week of 17th August 2026 No major cardiology congress fell this week. The strongest evidence came from The Lancet Healthy Longevity, JACC's special issue on obesity, JAMA Cardiology, and the European Heart Journal. Cardiology Intelligence Briefing: the trouble with average Cardiovascular evidence keeps hitting the same
Issue 19 | Week of 10 August 2026 No major cardiology congress fell this week. The strongest evidence came directly from European Heart Journal's advance articles, spanning pregnancy history, pharmacogenomics, diet, real-world heart failure practice, and cardio-oncology. Cardiology Intelligence Briefing: the case for granularity This week'
Issue 18 | Week of 3 August 2026 No major general cardiology congress fell in this window. The week's evidence arrived through routine journal publication across JAMA, JAMA Internal Medicine, JAMA Cardiology and Circulation. Cardiology Intelligence Briefing: the value already sitting in the system This week's five
Issue 17 | Week of 27 July 2026 No major cardiology congress fell this week. The most consequential evidence arrived through journal publication, and the five papers split cleanly into three states: established treatment hierarchies being reconsidered, proven interventions that still are not reaching enough patients, and one promising tool not
Issue 16 | Week of 20 July 2026 A quiet week on the conference calendar, but not a quiet one in the journals. Five papers this week span antithrombotic strategy, a novel mechanistic approach in hypertrophic cardiomyopathy (HCM), population-level prevention, and the accuracy of lipid measurement. Cardiology Intelligence Briefing: precision
Issue 15 | Week of 13 July 2026 No major cardiology congress fell this week. The evidence arrived through journal publication, and it was thinner than most weeks this year, but a single thread ran through what did appear: cardiology repeatedly asking whether a default setting, a default treatment, or a
Issue 14 | Week of 6 July 2026 No major cardiology congress fell this week. Instead the evidence arrived through journals and a co-published multisociety consensus document, and it clustered around a single question: not whether a treatment or a definition is correct in principle, but whether it is precise
Issue 13 | Week of 29 June 2026 No major cardiology congress fell this week, so the most consequential evidence arrived through journal publication. The thread running through it was time and trust: which of our habits hold up over the long run, which can be safely let go, and which
Issue 12 | Week of 22 June 2026 No major cardiology congress fell this week, and the most consequential evidence again arrived through journal publication. A single thread ran through it: cardiology is increasingly judged not on how a therapy performs at one or two years, but on whether its advantage
Issue 11 | Week of 15 June 2026 No major cardiology congress fell this week. The most consequential evidence arrived through journal publication, and a single thread ran through it: a treatment can be mechanistically sound, biologically attractive, or statistically associated with benefit, and still fail when it is tested properly.
Issue 10 | Week of 8 June 2026 No major cardiology congress fell this week. The European Renal Association (ERA) Congress in Glasgow, from 3 to 6 June, set the agenda, with the strongest cardiorenal evidence published simultaneously in JAMA and The Lancet. Cardiology Intelligence Briefing: where evidence stops Cardiovascular medicine
Issue 9 | Week of 1 June 2026 No major general cardiology congress fell in this window, and the week's most-discussed evidence arrived mainly through journal publication, including two early-phase platform studies in the New England Journal of Medicine. Cardiology Intelligence Briefing: the distance between promise and
Issue 8 | Week of 25 May 2026 EuroPCR took place in Paris from 19 to 22 May, dominating this week's evidence with three simultaneous publications across Circulation and EuroIntervention. Cardiology Intelligence Briefing: refining what we already do The five papers this week ask a narrower but increasingly important
Issue 7 | Week of 18 May 2026 Heart Failure 2026 closed in Barcelona on 12 May. The week that followed is lighter on the congress calendar but heavier on the questions large trials are not designed to answer. Cardiology Intelligence Briefing: between the landmarks Landmark cardiovascular trials earn their authority
Issue 6 | Week of 11 May 2026 Heart Failure 2026 is taking place in Barcelona from 9 to 12 May, dominating this week's evidence with four major publications across Nature Medicine and JAMA. Cardiology Intelligence Briefing: old drugs, new evidence Heart Failure 2026 week produced an unexpected protagonist:
Issue 5 | Week of 4 May 2026 Heart Rhythm 2026 closed in Chicago on 26 April. This issue covers one trial from the meeting alongside new publications in the New England Journal of Medicine (NEJM), the Lancet, and the Journal of the American College of Cardiology (JACC). Cardiology Intelligence Briefing:
Issue 4 | Week of 27 April 2026 ESC Preventive Cardiology 2026 took place in Ljubljana from 23 to 25 April and Heart Rhythm 2026 ran in parallel in Chicago from 23 to 26 April, making this one of the busiest weeks of the year for new cardiology evidence. Cardiology Intelligence
Issue 3 | Week of 20 April 2026 EHRA 2026 took place in Paris from 12 to 14 April, dominating this week's evidence in electrophysiology and device therapy. Cardiology Intelligence Briefing: trials that clarify, rather than settle This week's trials answer questions clinicians have been deciding on
Issue 2 | Week of 13 April 2026 ACC.26 produced the most concentrated wave of practice-changing cardiology evidence so far this year. With landmark trials still being digested from the conference, this issue covers five more key papers from ACC.26, each with important implications for clinical decision-making.
Cardiology
The week's most important cardiology evidence, with an honest assessment of what should and shouldn't change your practice.